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Abstract
Objectives. The aim of this investigation was to evaluate whether the adenosine triphosphate (ATP) biolumines-
cence method is an appropriate tool to assess the efficacy of antiseptic mouthrinses in terms of quantitative reduc-
tions of total viable microbial counts in mixed biofilm populations in vitro. 
Study Design. Three mouthrinses, containing respectively, chlorhexidine and cetylpyridinium chloride (CHX/
CPC), essential oils (EO) and amine fluoride/stannous fluoride (AFSF), as well as Phosphate Buffered Saline 
(PBS) used as control, were tested in an in vitro static biofilm model by ATP bioluminescence and compared to 
culture method. Biofilms were grown on saliva-coated hydroxyapatite disks for 72 hours and then exposed for 1 
minute to the mouthrinse or control by immersion. The antibacterial effect of the rinses was tested by analysis of 
variance. The reliability of the ATP bioluminescence method was assessed by calculating the Pearson correlation 
coefficients when compared to the viable cell counts obtained by culture.
Results. Using ATP bioluminescence, the antimicrobial activity of the tested mouthrinses was demonstrated when 
compared to the PBS control. The ATP bioluminescence values were significantly correlated (0.769, p<0.001) to 
the viable cell counts. CHX/CPC and AFSF showed similar antimicrobial activity, although AFSF had a less ho-
mogeneous effect, being both more effective than the EO rinse. 
Conclusion. ATP bioluminescence viability testing may be considered a useful tool to assess the in vitro efficacy 
of antibacterial compounds. In the proposed model, CHX/CPC and AFSF containing mouthrinses demonstrated 
superior antimicrobial activity, as compared to EO rinses, in a multispecies biofilm model. 
Key words: Biofilm, ATP bioluminescence,mouthrinse, essential oils, chlorhexidine, amine fluoride/stannous 
fluoride.
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Introduction
The effective control of the dental plaque is the key in 
the prevention of periodontal diseases. Several studies 
have demonstrated that the mechanical removal of the 
supragingival plaque through effective oral hygiene 
practices prevents or reverses the inflammatory status 
of the gingival tissues (1-3). Epidemiological data in-
dicates, however, that most individuals do not control 
plaque accumulation to a sufficient extent to prevent or 
control the occurrence of this condition, probably due 
to lack of motivation or skills, or both (3,4). In order 
to overcome this hindrance, antimicrobial oral hygiene 
products have been investigated in their efficacy to ad-
ditionally reduce plaque and gingivitis when used daily 
as adjuncts to mechanical plaque control. Since human 
dental plaque is a dynamic and complex biofilm where 
bacteria from saliva are adhered to tooth surfaces em-
bedded in a matrix of extracellular polymers (5), the 
efficacy of these antimicrobials must be tested within 
these environments rather than in planktonic status, due 
that bacteria in matured biofilms are less susceptible to 
antimicrobial agents because of several physical and 
biological factors that protect the bacterial consortia 
(6-8). 
Several studies have attempted to study the effect of 
mouthrinses in biofilms in vitro (8-12). Traditional-
ly, bacterial counts on agar plates was the method of 
choice for determination of bacterial viability, although 
this method has clear limitations, as the relatively long 
times needed for the colony growth, the differences in 
the growth media used or the likely growth inhibition by 
neighbouring cells (13). The use of morphological meth-
ods, as Confocal Laser Microscopy (CLSM), are useful 
to assess the structure and physiology of biofilms, but it 
does not allow the assessment of changes in the bacterial 
viability when biofilms are exposed to antiseptic com-
pounds (11). Also, culture-independent molecular meth-
ods for identification and quantification of oral bacteria 
have been extensively developed during recent years, 
but they are still not widely used in routine laboratories, 
due to the relatively long persistence of DNA after cell 
death, in the range between days to 3 weeks, what may 
overestimate the number of live cells after an antiseptic 
treatment (14). One possible alternative is the adenosine 
triphosphate (ATP) bioluminescence method, which has 
been utilized as a quantitative assay to evaluate viable 
bacteria in different biological samples, as well as in 
dental plaque (15-19). This method is based on the activ-
ity of the nucleotide ATP as a key element in the energy 
exchange of all biological systems. ATP serves as the 
principal immediate donor of energy and it is present in 
all metabolically active cells, since it links catabolic and 
anabolic processes. When cells are lysed, the released 
ATP can be measured by bioluminescence through its 
reaction with the luciferin-luciferase. This reaction is 
catalyzed by the enzyme luciferase obtained from the 
firefly Photinus pyralis that uses the chemical energy 
contained in the ATP molecule to drive the oxidative 
decarboxylation of luciferin. The MgATP2- converts 
the luciferin into a form, which is capable of being cata-
lytically oxidized by the luciferase in a high quantum 
yield chemiluminescent reaction at 562 nm (19). The 
main advantage of this technique is the provision of a 
rapid and real-time quantification of viable bacteria, 
however this method has not been previously utilized to 
test the antimicrobial efficacy of antiseptic mouthrinses 
in an in vitro complex oral biofilm model. 
There are few published in vitro biofilm models using 
a consortium of anaerobic bacteria where antimicro-
bial compounds can be adequately tested. Our research 
group has recently developed and tested such an in vitro 
biofilm model reporting its structure, viability and bac-
terial kinetics (20). This model uses six bacteria from 
the subgingival biofilm, containing initial (Streptococ-
cus oralis and Actinomyces naeslundii), early (Veillon-
ella parvula), secondary (Fusobacterium nucleatum), 
and late colonizers (Porphyromonas gingivalis and Ag-
gregatibacter actinomycetemcomitans).
It is, therefore, the main purpose of this investigation 
evaluate the possibility to use ATP bioluminescence 
method for rapid quantitative evaluation of viable total 
oral bacteria in biofilms samples, as compared to stand-
ard culture methods, to test the bactericidal efficacy of 
antiseptic mouthrinses. For this  purpose, we used three 
commercially available antiseptic mouthrinses contain-
ing respectively, chlorhexidine digluconate (CHX) and 
cetyl-pyridinium chloride (CPC), essential oils (EO), 
and amine fluoride/stannous fluoride (AMSF) in a test-
ed and validated in vitro biofilm model (20).
Material and Methods
-Bacterial strains and culture conditions
Standard reference strains of S. oralis CECT 907T, V. 
parvula NCTC 11810, A. naeslundii ATCC 19039, F. 
nucleatum DMSZ 20482, A. actinomycetemcomitans 
DSMZ 8324 and P. gingivalis ATCC 33277 were used. 
Bacteria were grown on blood agar plates (Blood Agar 
Oxoid No 2; Oxoid, Basingstoke, UK), supplemented 
with 5% (v/v) sterile horse blood (Oxoid), 5.0 mg/mL 
hemin (Sigma, St. Louis, MO, USA) and 1.0 mg/mL 
menadione (Merck, Darmstadt, Germany) in anaerobic 
conditions (10% H2, 10% CO2, and balance N2) at 37°C 
for 24-72 h. 
-Saliva Preparation
Un-stimulated saliva was obtained from healthy volun-
teers in 10 ml aliquots at least 1.5 h after eating, drink-
ing or tooth brushing. Saliva preparation were carried 
out as previously described (20). The efficacy of this 
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protocol was assessed by plating processed saliva sam-
ples onto supplemented blood agar plates for 72 h at 
37ºC and confirmed by the lack of any bacterial growth 
on either aerobically or anaerobically incubated plates.
-Biofilm development assays
Biofilms were developed as previously described (20). In 
brief, pure cultures were grown anaerobically in a pro-
tein rich medium containing brain-heart infusion (BHI) 
(Becton, Dickinson and Company, USA) supplemented 
with 2.5 g/L mucin (Oxoid), 1.0 g/L yeast extract (Ox-
oid), 0.1 g/L cysteine (Sigma), 2.0 g/L sodium bicarbo-
nate (Merck), 5.0 mg/mL hemin (Sigma), 1.0 mg/mL me-
nadione (Merck) and 0.25% (v/v) glutamic acid (Sigma). 
The bacterial growth was adjusted by spectrophotometry 
to mid-exponential phase with the objective to obtain a 
solution in modified BHI medium containing 103 colony 
forming units (CFU)/mL for S. oralis, 105 CFU/mL for V. 
parvula and A. naeslundii, and 106 CFU/mL for F. nucle-
atum, A. actinomycetemcomitans and P. gingivalis. Ster-
ile calcium hydroxy-apatite disks of 7 mm of diameter 
and 1.8 (SD=0.2) mm of thickness (Clarkson Chroma-
tography Products, Williamsport, PA, USA) were coated 
with treated saliva for 4 h at 37ºC in sterile plastic tubes, 
and then placed in the wells of a 24-well tissue culture 
plate (Greiner Bio-one, Frickenhausen, Germany). Each 
well was inoculated with 1.5 mL pooled bacteria culture 
prepared and incubated in anaerobic conditions (10% H2, 
10% CO2, and balance N2) at 37°C for 72 h. The plates 
employed for assessing the sterility of the culture me-
dium were used as controls. 
-Tested mouthrinses
The following commercially available mouthrinses were 
evaluated: Perioaid treatment® (Dentaid, Cerdanyola, 
Spain) containing 0.12% CHX and 0.05% CPC as active 
ingredients, without alcohol (CHX/CPC); Listerine® 
(Johnson & Johnson, Madrid, Spain) containing a com-
bination of four essential oils (EO) as active ingredients 
(thymol 0.06%, eucalyptol 0.09%, methyl salicylate 
0.06%, menthol 0.01%) in an alcoholic solution; and 
Meridol® (GABA GmbH, Lörrach, Switzerland), con-
taining amine fluoride/stannous fluoride (AFSF) with-
out alcohol. PBS and absolute ethanol (EtOH) served as 
the negative and positive controls, respectively.
-Exposure to oral rinses
To evaluate the bactericidal action of CHX/CPC, EO 
and AFSF wells containing 2 mL of suspension of the 
tested products, EtOH and PBS were prepared and once 
the 72-h biofilms were formed over HA discs they were 
transferred to the wells. Following a single 1 min-expo-
sure, discs were sequentially washed three times in 2 
mL of fresh PBS (immersion time per rinse, 10 s).
In each experiment, the three mouthrinses and the con-
trol solutions were tested together. The experiments 
were repeated nine times, on different days and with 
fresh bacterial cultures. 
-Cell viability assessed by ATP bioluminescence
Immediately after treatment, each HA disc was trans-
ferred to sterile plastic tubes containing 1.0 mL of PBS, 
and vortexed vigorously for 2 min, to harvest adherent 
cells. The BacTiter-Glo viability assay kit® (Promega, 
Madison, WI, USA) was utilized to assess the ATP 
bioluminescence, following the manufacturer’s instruc-
tions. This assay is based on the luciferase-catalysed 
reaction of luciferin and ATP and thus it quantifies the 
ATP present signalling the presence of metabolically 
active cells. In brief, 400 µL of BacTiter-Glo reagent 
was added with gentle stirring to a plastic cuvette con-
taining 400 µL of disaggregated biofilm cells and incu-
bated in darkness for 5 min at room temperature. The 
luminescent signal was recorded for 1 s per cuvette into 
a 1250 Luminometer (LKB-Wallac, Turku, Finland). 
The light output and ATP measurements were done at 
room temperature and expressed in Relative Light Units 
(RLUs) per mL. The culture medium and PBS, in the 
absence of cells, served as negative controls since they 
contained no detectable ATP.
-Cell viability assessed by culture methods
Using the same biofilms (as described in the previous 
section), standard microbiologic culture methods were 
carried out and the number of obtained colonies was 
compared with the ATP bioluminescence results. In 
brief, the disaggregated biofilms were subjected to 10-
fold serial dilutions in PBS and then plated onto blood 
agar plates (Blood Agar Oxoid No 2), supplemented 
with 5% (v/v) sterile horse blood (Oxoid), 5.0 mg/mL 
hemin (Sigma) and 1.0 mg/mL menadione (Merck) in 
anaerobic conditions (10% H2, 10% CO2, and balance 
N2) at 37°C. All plating procedures were conducted in 
duplicate, and the number of colonies (between 30 and 
300) were used to calculate the number of viable bacte-
ria from a particular dilution and averaged to determine 
mean values colony forming units (CFU/mL).
-Statistical analysis
Data were calculated as RLU/mL, for samples analyzed 
by ATP bioluminescence, and as CFU/mL, for samples 
analyzed by culture-method. The proportions of vital 
cells after mouthrinse contact, as compared to the nega-
tive control, were calculated for both techniques. The 
vitality ratio was calculated by dividing the vitality 
value for each mouthrinse to the one given by the nega-
tive control.
An experiment-level analysis was performed for each 
study parameter (n=9). Kolmogorov-Smirnov good-
ness-of-fit tests were computed for each variable. Data 
were expressed as means and standard deviations (SD). 
Box-plots were used for the graphic presentation of 
data. To test the effect of each mouthrinse on cell vital-
ity, analysis of variance (ANOVA) and post hoc-testing 
with Bonferroni’s correction for multiple comparisons 
were used for both techniques (mean viable cell count 
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as CFU/mL, and the ATP-driven bioluminescence de-
terminations, as RLU/mL). To determine the reliability 
of ATP-driven bioluminescence to measure cell vitality, 
Pearson correlation coefficient was determined between 
the ratio of vitality obtained by culture and ATP-driven 
bioluminescence. In addition, the existence of differ-
ences between ratios of vitality obtained by each tech-
nique was assessed by the Student t-test for independent 
samples. 
Results were considered statistically significant at 
p<0.05. A software package (IBM® SPSS® Statistics 
19.0) was used for all data analysis.
                                                                                                                                                  
Results
-ATP-driven bioluminescence
All tested mouthrinses reduced the amounts of ATP-
driven bioluminescence, as compared to the negative 
control solution. Statistically significant differences in 
bioluminescence were observed for CHX/CPC (mean 
difference 217.08 RLU/mL, 95% confidence interval 
–CI- [87.84, 346.32]; p<0.001) and AFSF treatment 
(243.69, CI [114.45, 372.93]; p<0.001) when compared to 
the negative control. No statistically significant chang-
es in bioluminescence were found for EO when com-
pared to the negative control (119.79, CI [-9.45, 249.04]; 
p=0.088). No statistically significant differences were 
found when the mouthrinses where compared. (Fig. 1) 
presents the comparative effect of CHX/CPC, EO and 
AFSF mouthrinses on the cell viability of biofilms as-
sessed by ATP bioluminescence (RLU/mL). The lowest 
values were found for AFSF (233.08; SD=83.13), fol-
lowed by CHX/CPC (259.69; SD=78.29), EO (356.98; 
SD=63.01) and the negative control (476.78; SD=53.25). 
AFSF, however, demonstrated the largest variability in 
the response.
-Culture-dependent method
Figure 2 depicts the effect of the tested mouthrinses over 
the biofilms, as assessed by viable cell counts obtained 
by standard culturing (CFU/mL). The lowest cell viabil-
ity values were found for CHX/CPC (1.38x108 CFU/mL; 
SD=8.54x107), followed by AFSF (1.42x108; SD=9.03 
x107), EO (1.67x108; SD=1.17x108) and the negative 
control (2.55x108; SD=1.63x108). All groups presented 
large interquartile-range variability, being the largest 
deviations from the obtained median values shown by 
AFSF and EO. No statistically significant differences in 
viability cell counts were observed among mouthrinses 
or between each mouthrinse and the negative control.
-Comparison between ATP-driven bioluminescence 
and culture-dependent method
Table 1 shows the comparisons between obtained ratios 
of vitality by ATP bioluminescence and by culture. A 
Fig. 1. Box plots showing ATP bioluminescence values from in vitro subgingival biofilms after treatment 
with the mouthrinses containing chlorhexidine digluconate and cetylpyridinium chloride (CHX/CPC), 
amine fluoride/stannous fluoride (AFSF) and essential oils (EO) compared to a negative PBS control and 
a positive EtOH control (n = 9). Differences between control and CHX/CPC and AFSF treatments were 
statistically significant (p<0.005). Differences between treatments were not significant. (RLU: Relative 
Light Units).
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statistically significant correlation was observed (r=0.769, 
p<0.001) between both techniques. No statistically signifi-
cant differences were found between the ratios of vitality 
for each mouthwash, when calculated by either technique. 
Discussion
The objective of this study was to validate the use of 
the ATP bioluminescence method for rapid quantita-
tive evaluation of viable total oral bacteria in biofilm 
samples after exposure to the antimicrobial agents. 
The obtained results have shown that the ATP biolu-
minescence method was capable of quantifying bacte-
rial vitality, when applied to a validated in vitro biofilm 
model. In fact the relative antimicrobial effect of three 
tested antimicrobial compounds was demonstrated with 
this method when compared with a negative control and 
these results were similar when compared with standard 
culturing techniques.
The exposure of a relatively mature biofilm to a 1-min con-
tact with the tested antimicrobials resulted in a bactericidal 
effect, demonstrating a significant reduction in the viable 
microbial load when compared to the negative control. EO 
Fig. 2. Box plots showing viable cell count as Colony-Forming Units per mL values from in vitro subgingi-
val biofilms after treatment with the mouthrinses containing chlorhexidine digluconate and cetylpyridinium 
chloride (CHX/CPC), amine fluoride/stannous fluoride (AFSF) and essential oils (EO) compared to a nega-
tive PBS control and a positive EtOH control (n = 9). Differences between control and all treatments were 
not significant. Differences among treatments were not significant.
Group Technique Ratio of vitality (mean)
Standard 
deviation p value 
CHX/CPC/Control ATP-Bioluminescence 0.59 0.27 p=0.700 Viable cell count 0.56 0.14 
AFSF /Control 
ATP-Bioluminescence 0.52 0.20 p=0.696 
Viable cell count 0.56 0.13 
EO/control ATP-Bioluminescence 0.81 0.26 p=0.551 Viable cell count 0.73 0.25 
Table 1. Ratios of vitality obtained with each mouthrinse by ATP-Bioluminescence and viable cell count. 
CHX/CPC, chlorhexidine digluconate and cetylpiridinium chloride; AFSF, amine fluoride/stannous 
fluoride; EO, essential oils. Student t-test for independent samples.
Med Oral Patol Oral Cir Bucal. 2013 Jan 1;18 (1):e86-92.                                                                                             Validation of ATP bioluminescence in an in vitro subgingival-biofilm model 
e91
was substantially less effective than CHX/CPC and AFSF, 
which depicted similar antimicrobial activity, although 
AFSF demonstrated a higher variability in its antimicro-
bial effect. CHX/CPC, therefore, demonstrated the most 
efficacious activity in this in vitro biofilm model. These 
results are in agreement with the reported significant an-
timicrobial effect of a CHX formulation, as compared to 
a control, when evaluated by ATP bioluminescence in P. 
gingivalis biofilms (21), as well as with those reported in 
other studies using different biofilm models (9,10,11,22). 
All these experiments reported that the CHX-containing 
mouthrinses had significantly higher bactericidal activity 
than EO- and AFSF-containing formulations. Multiple 
long-term home-use randomized clinical trials have also 
demonstrated that CHX-based products are the most ef-
fective against plaque and gingivitis, with demonstrated 
antiplaque and antigingivitis effect (23). In addition, CHX-
formulations have demonstrated better clinical results 
when compared to EO- and AFSF-formulations (24,25). 
The microbiological assay used in this study was the 
ATP bioluminescence technique. This method has previ-
ously shown valid to provide a real-time estimation of 
total viable bacteria in biological sample (19), although 
not tested before with a biofilm containing subgingival 
bacteria. Prior studies have shown a correlation between 
ATP measurements and the viable bacterial number ob-
tained by standard culturing techniques (17,26,27) for the 
determination of total oral bacteria. The data from this 
investigation also showed a statistically significant corre-
lation (Pearson correlation coefficient of 0.769, p<0.001) 
between both techniques. In addition, no statistically sig-
nificant differences between the relative proportions of 
cell vitality values for each mouthwash calculated with 
both techniques were observed. These results confirm, 
therefore, the ability of this ATP technology as a suitable 
method to evaluate bacterial viability in an oral biofilm 
model, since the luminescent signal generated during 
cell lyses was proportional to the amount of ATP present. 
This technique has also being recently applied in other 
oral investigations, such as: the study of different treat-
ment approaches on the removal of early plaque biofilms 
grown on titanium implants (16), the detection of cari-
ogenic bacteria genes by a combination of allele-specific 
polymerase chain reactions and a novel bioluminescent 
pyrophosphate assay (15) and in a randomized clinical 
study of plaque retention by self-ligating versus elasto-
meric orthodontic brackets (17). 
In conclusion, the results of the present study have vali-
dated the ATP bioluminescence method for evaluating 
the bacterial viability in an in vitro biofilm model. It has 
also been demonstrated the utility of this in vitro biofilm 
model to test the antimicrobial effect of mouthrinses. 
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